FDA Pulls Plug on JUUL Products
The US Food and Drug Administration has issued marketing denial orders to JUUL Labs, essentially pulling the plug on JUUL vaping products.
FDA
FDA Approves Skyrizi for Moderately to Severely Active Crohn Disease
Skyrizi is first specific interleukin-23 approved to treat Crohn disease.
Olumiant Approved for Severe Alopecia Areata
The approval was based on data from the phase 2/3 BRAVE-AA1 and phase 3 BRAVE-AA2 trials, which included adults with severe alopecia areata.
FDA Aims To Improve Medical Device Security
The agency has issued proposed draft recommendations to guide incorporation of cybersecurity protections into medical devices at the time of manufacture.
Top April 2022 FDA Approvals
April 2022 FDA approvals include treatments for pediatric urinary tract infections, topical rosacea, vulvovaginal candidiasis, and various types of cancer.
FDA Moves to Ease Nationwide Shortage of Baby Formula
The agency’s latest moves should help ease the dire situation many mothers face.
COVID-19 Drug Paxlovid Might Also Fight Long COVID
Series of case reports shows some success with Paxlovid in treating patients with long COVID.
Warning Letters Sent to Companies Marketing Delta-8 THC Products as Treatments
The FDA has expressed serious concerns related to the potential health effects for patients who have consumed delta-8 THC products.
FDA Clears Automated, Wearable 3D Breast Ultrasound Device
In 2 minutes, the portable ATUSA system automatically scans the entire breast volume and provides 3D visualization of the breast tissue.
Top March 2022 FDA Approvals
March 2022 FDA approvals include treatments for Alzheimer disease, endometrial carcinoma, metastatic melanoma, and a genetic seizure disorder.
- Loading...
Loading...
Next post in Practice Management Information Center
Loading... 
Loading...